CBE & PDS presents a Career Talk Seminar, Shravanthi Reddy, Ph.D., COO ClearSight Vice President of R&D at Sharklet Technologies

Thursday, January 7, 2016, 2:00pm in Elings Hall room #1601

Current Topics in Bioengineering Career Talk

Thursday, January 7, 2016

Elings 1601

2:00– 3:00 pm

*Light refreshments will be provided*

RSVP at:


Shravanthi Reddy, Ph.D.

COO ClearSight

Vice President of R&D at Sharklet Technologies


Funding Your Startup with Non-Dilutive Funding – Keys to Success for Obtaining Small Business Innovation Research (SBIR) Grants

Have you thought about commercializing your research, but feel unsure where to find the funding? Even in these times of highly available seed funding from private investors, why give up a piece of your company before you have to? This talk will focus on the SBIR programs that are offered by a number of government agencies to help fund startup companies with innovative technologies, with emphasis on the NIH SBIR program. We will discuss how to put together a strong proposal, how these proposals are reviewed and scored, strategy on how to go after each “phase” of funding, and how to make sure the work you are doing is compatible with your plan for your business. We will touch on how the SBIR program should ideally fit into your plans for obtaining other sources of funding as well.



BIO: Dr. Shravanthi Reddy has been working with medical device startups for the last eight years. Currently she is COO of ClearSight, a startup medical device company working on a novel intraocular lens, and VP of R&D at Sharklet Technologies. Although she has a technical background, with a PhD in Chemical Engineering, she has been involved with business development and funding efforts while also building R&D programs. Reddy has completed licensing and joint development deals with Fortune 500 and 1000 companies, received over $6 million in non-dilutive government funding for her companies (via NIH SBIR and DOD grants) and worked with her CEO to garner about $6 million in private investments from venture groups.